3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Hyperprolactinemia: new trials by email Literature Review of Hyperprolactinemia trials Research Report on Hyperprolactinemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Administration of Kisspeptin in Patients With Hyperprolactinemia Kisspeptin 112-121, GnRH - Hyperprolactinemia, Hypogonadism | Phase 2 | Completed | Massachusetts General Hospital | 36 | 2017-11-17 | 2024-10-01 |
| Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole Ropinirole - Hyperprolactinemia, Prolactinoma | Phase 1 / Phase 2 | Completed | Columbia University | 16 | 2016-09-16 | 2024-06-04 |
| Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia PGD granules, Placebo - Schizophrenia, Schizophrenic Disorder | Phase 2 | Completed | The University of Hong Kong | 103 | 2013-01-01 | 2015-05-07 |
Hypogonadism (1) · Prolactinoma (1) · Schizophrenia (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Endocrine System Diseases (3) · Hyperpituitarism (3) · Hypothalamic Diseases (3) · Nervous System Diseases (3) · Pituitary Diseases (3) · Adenoma (1) · Endocrine Gland Neoplasms (1) · Gonadal Disorders (1) · Mental Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1)
Gonadotropin-Releasing Hormone (1) · ropinirole (1)
Columbia University (1) · Massachusetts General Hospital (1) · The University of Hong Kong (1)
United States (2) · China (1)
Gabrielle Page-Wilson, M.D. (1) · Stephanie Seminara, MD (1) · Zhang-Jin Zhang, MMed, PhD (1)
R21DK112093 (1)